320 related articles for article (PubMed ID: 28789654)
1. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.
Demková K; Kozárová M; Malachovská Z; Javorský M; Tkáč I
Vasa; 2018 Feb; 47(2):131-135. PubMed ID: 29313442
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.
Niu Y; Zhang W; Yang Z; Li X; Wen J; Wang S; Zhang H; Wang X; Zhou H; Fang W; Qin L; Su Q
BMC Cardiovasc Disord; 2015 Aug; 15():86. PubMed ID: 26260869
[TBL] [Abstract][Full Text] [Related]
4. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
5. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
6. Inverse regulation of serum osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand levels in patients with leg lesional vascular calcification: An observational study.
Moon AR; Park Y; Chang JH; Lee SS
Medicine (Baltimore); 2019 Mar; 98(10):e14489. PubMed ID: 30855435
[TBL] [Abstract][Full Text] [Related]
7. High circulating osteoprotegerin levels are associated with non-zero blood groups.
Nagy EE; Varga-Fekete T; Puskas A; Kelemen P; Brassai Z; Szekeres-Csiki K; Gombos T; Csanyi MC; Harsfalvi J
BMC Cardiovasc Disord; 2016 May; 16(1):106. PubMed ID: 27387019
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status.
O'Sullivan EP; Ashley DT; Davenport C; Kelly J; Devlin N; Crowley R; Leahy AL; Kelly CJ; Agha A; Thompson CJ; O'Gorman DJ; Fitzgerald P; Smith D
Thromb Res; 2010 Dec; 126(6):e423-7. PubMed ID: 20932553
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis.
Lin WC; Tsai JP; Lai YH; Lin YL; Kuo CH; Wang CH; Hsu BG
Ren Fail; 2020 Nov; 42(1):131-136. PubMed ID: 31950864
[TBL] [Abstract][Full Text] [Related]
10. Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population.
Biscetti F; Tinelli G; Rando MM; Nardella E; Cecchini AL; Angelini F; Straface G; Filipponi M; Arena V; Pitocco D; Gasbarrini A; Massetti M; Flex A
Cardiovasc Diabetol; 2021 May; 20(1):114. PubMed ID: 34044825
[TBL] [Abstract][Full Text] [Related]
11. Vascular calcification biomarkers and peripheral arterial disease.
Kapetanios D; Karkos C; Giagtzidis I; Papazoglou K; Kiroplastis K; Spyridis C
Int Angiol; 2016 Oct; 35(5):455-9. PubMed ID: 26044839
[TBL] [Abstract][Full Text] [Related]
12. Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population.
Rando MM; Biscetti F; Cecchini AL; Nardella E; Nicolazzi MA; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
Cardiovasc Diabetol; 2022 Oct; 21(1):214. PubMed ID: 36244983
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
Ahmed S; Sobh R
Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
[TBL] [Abstract][Full Text] [Related]
14. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
15. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.
Bourron O; Aubert CE; Liabeuf S; Cluzel P; Lajat-Kiss F; Dadon M; Komajda M; Mentaverri R; Brazier M; Pierucci A; Morel F; Jacqueminet S; Massy ZA; Hartemann A
J Clin Endocrinol Metab; 2014 Nov; 99(11):4250-8. PubMed ID: 25013993
[TBL] [Abstract][Full Text] [Related]
16. Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study.
Nardella E; Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Massetti M; Gasbarrini A; Flex A
Cardiovasc Diabetol; 2023 Jun; 22(1):136. PubMed ID: 37308885
[TBL] [Abstract][Full Text] [Related]
17. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
[TBL] [Abstract][Full Text] [Related]
18. Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.
Poulsen MK; Nybo M; Dahl J; Hosbond S; Poulsen TS; Johansen A; Høilund-Carlsen PF; Beck-Nielsen H; Rasmussen LM; Henriksen JE
Cardiovasc Diabetol; 2011 Aug; 10():76. PubMed ID: 21838881
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease.
Ziegler S; Kudlacek S; Luger A; Minar E
Atherosclerosis; 2005 Sep; 182(1):175-80. PubMed ID: 16115489
[TBL] [Abstract][Full Text] [Related]
20. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
